Stereotaxis (STXS) Reiterated at Market Outperform by Citizens Amid Strategic Transformation

April 1, 2026 5:11 AM EDT Send to a Friend
Citizens analyst Daniel Stauder reiterated a Market Outperform rating and $4.00 price target on Stereotaxis (NYSE: STXS).The analyst commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login